| Cancer |
0 |
0.56 |
| Anemia |
0 |
0.46 |
| Biologic Therapy |
0 |
0.37 |
| Central Nervous System |
0 |
0.37 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Tumor |
0 |
0.37 |
| HIV Infection |
0 |
0.35 |
| Toxicology |
0 |
0.35 |
| Neuroendocrine Tumor |
0 |
0.95 |
| Hemangioblastomas |
0 |
0.94 |
| Hypoxia |
0 |
0.28 |
| Von Hippel-Lindau Disease |
0 |
1 |
| Small Molecule Inhibitor |
0 |
0.13 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.1 |
| Contraception |
0 |
0.1 |
| Headache |
0 |
0.1 |
| Pregnancy |
0 |
0.1 |
| Clinical Research |
0 |
0.09 |
| Dizziness |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Hemoglobin |
0 |
0.09 |
| Hormonal Contraception |
0 |
0.09 |
| Nausea |
0 |
0.09 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.09 |
| Surgery |
0 |
0.09 |